Zenith Drugs Limited IPO

Zenith Drugs' IPO offers 51,48,800 shares worth INR 40.68 crores. Funds will boost new unit machinery, block upgrades, working capital, and general needs.

Important Details

Date: Feb 19 to Feb 22, 2024 Listing Date: Feb 27, 2024 Price: INR 75-79 per share Lot Size: 1600 Shares Total Issue Size: INR 40.68 crores

Fundamental Analysis

Zenith Drugs IPO reveals strong growth with rising revenue, doubled equity, increased profitability, high RoNW, growing EPS, and improved asset management.

Peer Comparison

Zenith Drugs excels with a 29.88% RoNW and ₹4.29 EPS, outperforming Sudarshan Pharma and Sigachi Industries in profitability and operational efficiency.


Zenith Drugs aims to purchase machinery, upgrade the manufacturing block, and meet working capital needs. The balance funds support general corporate goals.

Risks And Challenges

Zenith Drugs faces global legal uncertainties, operational impacts, and API supplier challenges, risking business continuity and quality assurance.

Apply for Zenith Drugs Limited IPO with Alice Blue Completely Free of Cost.



*T&C Apply